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Pseudomonas  aeruginosa,  a  Gram-negative  bacterium,  an
opportunistic  pathogen  that  infects  individuals  suffering  from
reduced immunity or damaged tissue.  The treatment of  these
infections has become a major  problem due to its  increasing
antibiotic  resistance.  Many  multi-drug  resistant  isolates  of  P.
aeruginosa  can  thwart  most  antibiotic  classes  including  ?-
lactams,  fluoroquinolones,  and  aminoglycosides.  Its  ability  to
combat ?-lactams is in part due to expression of AmpC, a major
chromosomally encoded ?-lactamase. The expression of ampC is
positively  regulated  by  AmpR.  Besides  antibiotic  resistance,
AmpR  is  an  important  regulator  of  various  factors  that  are
required for establishing acute and chronic infections. Loss of
ampR makes  P.  aeruginosa  susceptible  to  ?-lactams and  less
virulent  than  the  wild  type.  We hypothesize  that  AmpR is  a
potential therapeutic target. In the absence of new drugs in the
pipeline,  the  aim  of  this  study  is  to  find  an  AmpR-specific
inhibitor to assist and improve the use of currently available ?-
lactam treatment.  A small-molecule  library from Torrey Pines
Institute will be used in this study. Two reporter systems, lux and
lacZ,  fused to a PampC  promotor will  be used to assess AmpR
activity. Positive hits will be those that inhibit 50% PampC activity
in the presence of sub inhibitory concentration of imipenem, a ?-
lactam. The top positive hits will be screened for their ability to
cause  human  cell-cytotoxicity.  The  non-cytotoxic  hits  will  be
assessed for their ability to affect P. aeruginosa virulence and
antibiotic resistance using various in vitro assays. Determination
of potential AmpR inhibitors will prove to be useful in fighting off
infections and may save countless patients suffering from these
infections.
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